z-logo
open-access-imgOpen Access
Use of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes and Cardiovascular Disease
Author(s) -
Michael C. Honigberg,
Lee-Shing Chang,
Darren K. McGuire,
Jorge Plutzky,
Vanita R. Aroda,
Muthiah Vaduganathan
Publication year - 2020
Publication title -
jama cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.108
H-Index - 63
eISSN - 2380-6591
pISSN - 2380-6583
DOI - 10.1001/jamacardio.2020.1966
Subject(s) - medicine , semaglutide , liraglutide , dulaglutide , type 2 diabetes , diabetes mellitus , hypoglycemia , exenatide , glycemic , intensive care medicine , adverse effect , clinical trial , insulin , endocrinology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom